A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
Clinical trial NCT00744562 · COMPLETED
Trial details
- NCT number
- NCT00744562
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2011-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.